Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inhibition of platelet aggregation as a surrogate marker

H Narjes1, T H Müller, H Weisenberger

  • 1Dr. K. Thomae GmbH, Biberach, Germany.

Journal of Clinical Pharmacology
|January 1, 1997
PubMed
Summary

Evaluating antiplatelet drug efficacy requires tailored methods. Combining general and specific tests can predict drug effectiveness and guide clinical trial planning for antiplatelet therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality.

Vox sanguinis·2018
Same author

Evaluation of droplet digital PCR for quantification of residual leucocytes in red blood cell concentrates.

Vox sanguinis·2017
Same author

Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates.

Vox sanguinis·2016
Same author

Tolerance of platelet concentrates treated with UVC-light only for pathogen reduction--a phase I clinical trial.

Vox sanguinis·2015
Same author

MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study.

African health sciences·2013
Same author

Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Area of Science:

  • Pharmacology
  • Cardiovascular Research
  • Biomedical Science

Background:

  • Antiplatelet drugs are crucial in preventing thrombotic events.
  • Assessing the efficacy of antiplatelet agents requires reliable methods.
  • Existing methods may not fully capture the diverse mechanisms of antiplatelet action.

Purpose of the Study:

  • To evaluate the predictive value of various methods for assessing antiplatelet effects.
  • To determine the suitability of these methods as surrogate markers for clinical trial planning.
  • To examine drug-specific assays for different antiplatelet mechanisms.

Main Methods:

  • Investigated platelet aggregation in platelet-rich plasma and whole blood ex vivo.
  • Assessed thrombus formation on a thrombogenic surface.

Related Experiment Videos

  • Examined the effects of acetylsalicylic acid-dipyridamole and a fibrinogen receptor antagonist on these tests.

    • Main Results:

    • Drug-induced inhibition of platelet aggregation involves metabolic or receptor-level interactions.
    • Specific methods are needed to assess different modes of action (e.g., cyclooxygenase inhibition, receptor blockade).
    • A combination of general and specific methods showed predictive value.

    Conclusions:

    • The choice of method for evaluating antiplatelet effects should match the drug's mechanism of action.
    • Tailored assays are essential for accurately assessing drug efficacy.
    • Combined general and specific methods can serve as effective surrogate markers for planning clinical trials.